Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadjuvant or adjuvant treatment.
Sponsor: Panbela Therapeutics, Inc.
Check if you qualify for this pancreatic cancer clinical trial in Rochester, NY
If you're searching for pancreatic cancer treatment options in Rochester, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.